Cargando…
Genomic landscape in acute myeloid leukemia and its implications in risk classification and targeted therapies
Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy in terms of clinical features, underlying pathogenesis and treatment outcomes. Recent advances in genomic techniques have unraveled the molecular complexity of AML leukemogenesis, which in turn have led to refinement of risk stra...
Autores principales: | Hou, Hsin-An, Tien, Hwei-Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372828/ https://www.ncbi.nlm.nih.gov/pubmed/32690020 http://dx.doi.org/10.1186/s12929-020-00674-7 |
Ejemplares similares
-
Molecular landscape and targeted therapy of acute myeloid leukemia
por: Gu, Runxia, et al.
Publicado: (2018) -
Targeted Therapies for the Evolving Molecular Landscape of Acute Myeloid Leukemia
por: Ahmadmehrabi, Khashayar, et al.
Publicado: (2021) -
High expression of dedicator of cytokinesis 1 (DOCK1) confers poor prognosis in acute myeloid leukemia
por: Lee, Sze-Hwei, et al.
Publicado: (2017) -
Functional Genomic Landscape of Acute Myeloid Leukemia
por: Tyner, Jeffrey W., et al.
Publicado: (2018) -
Genomic landscape of hyperleukocytic acute myeloid leukemia
por: Largeaud, Laetitia, et al.
Publicado: (2022)